1. Baron F, Storb R, Little MT. Hematopoietic cell transplantation: five decades of progress. Arch Med Res. 2003;34:528–544. [PubMed] [Google Scholar]
2. Haider H, Ashraf M. Bone marrow stem cell transplantation for cardiac repair. Am J Physiol Heart Circ Physiol. 2005;288:2557–2567. [PubMed] [Google Scholar]
3. Iannone R, Casella JF, Fuchs EJ, Chen AR, Jones RJ, Woolfrey A, et al. Results of minimally toxic non-myeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant. 2003;9:519–528. [PubMed] [Google Scholar]
4. Ikehara S. Bone marrow transplantation: a new strategy for intractable diseases. Drugs Today (Barc) 2002;38:103–111. [PubMed] [Google Scholar]
5. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med. 2001;7:259–264. [PubMed] [Google Scholar]
6. Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) Bone Marrow Transplant. 2002;30:215–222. [PubMed] [Google Scholar]
7. Stocum DL, Zupanc GK. Stretching the limits: stem cells in regeneration science. Dev Dyn. 2008;237:3648–3671. [PubMed] [Google Scholar]
8. Alper J. Geron gets green light for human trial of ES cell-derived product. Nat Biotechnol. 2009;27:213–214. [PubMed] [Google Scholar]
9. Sputtek A. Cryopreservation of red blood cells, platelets, lymphocytes and stem cells. In: Fuller B, Grout B, editors. Clinical Applications of Cryobiology. Boca Raton, FL: CRC Press; 1991. pp. 95–147. [Google Scholar]
10. Sputtek A. Kryokonservierung von Blutzellen und hamatoppoetischen stammzellen. In: Mueller-Eckhart C, Kiefel V, editors. Transfusionsmedizin. Berlin: Springer; 2004. (Fre). [Google Scholar]
11. Sputtek A, Gutensohn K, Hummel K, Loliger C, Kuhnl P. Zur Kryokonsevierung von Blutstammzellen. J Lab Med. 1996;20:70–77. (Fre). [Google Scholar]
12. Sputtek A, Sputtek R. Cryopreservation in Transfusion Medicine and Hematology. In: Fuller BJ, Lane N, Benson E, editors. Life in the Frozen State. Boca Raton, FL: CRC Press; 2004. pp. 483–504. [Google Scholar]
13. Areman EM, Sacher RA, Deeg HJ. Processing and storage of human bone marrow: a survey of current practices in North America. Bone Marrow Transplant. 1990;6:203–209. [PubMed] [Google Scholar]
14. Berz D, McCormack EM, Winer ES, Colvin GA, Quesenberry PJ. Cryopreservation of hematopoietic stem cells. Am J Hematol. 2007;82:463–472. [PMC free article] [PubMed] [Google Scholar]
15. Alessandrino P, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L, et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant. 1999;23:533–537. [PubMed] [Google Scholar]
16. Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant. 2000;25:1299–1301. [PubMed] [Google Scholar]
17. Davis J, Rowley SD, Santos GW. Toxicity of autologous bone marrow graft infusion. Prog Clin Biol Res. 1990;333:531–540. [PubMed] [Google Scholar]
18. Hoyt R, Szer J, Grigg A. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant. 2000;25:1285–1287. [PubMed] [Google Scholar]
19. Martino M, Morabito F, Messina G, Irrera G, Pucci G, Iacopino P. Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients. Haematologica. 1996;81:59–61. [PubMed] [Google Scholar]
20. Stroncek DF, Fautsch SK, Lasky LC, Hurd DD, Ramsay NK, McCullough J. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion. 1991;31:521–526. [PubMed] [Google Scholar]
21. Zenhausern R, Tobler A, Leoncini L, Hess OM, Ferrari P. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol. 2000;79:523–526. [PubMed] [Google Scholar]
22. Abrahamsen JF, Bakken AM, Bruserud O. Cryopreserving human peripheral blood progenitor cells with 5-percent rather than 10-percent DMSO results in less apoptosis and necrosis in CD34+ cells. Transfusion. 2002;42:1573–1580. [PubMed] [Google Scholar]
23. Galmes A, Gutierrez A, Sampol A, Canaro M, Morey M, Iglesias J, et al. Long-term hematological reconstitution and clinical evaluation of autologous peripheral blood stem cell transplantation after cryopreservation of cells with 5% and 10% dimethylsulfoxide at −80°C in a mechanical freezer. Haematologica. 2007;92:986–989. [PubMed] [Google Scholar]
24. Bakken AM. Cryopreserving human peripheral blood progenitor cells. Curr Stem Cell Res Ther. 2006;1:47–54. [PubMed] [Google Scholar]
25. Sasnoor LM, Kale VP, Limaye LS. Supplementation of conventional freezing medium with a combination of catalase and trehalose results in better protection of surface molecules and functionality of hematopoietic cells. J Hematother Stem Cell Res. 2003;12:553–564. [PubMed] [Google Scholar]
26. Limaye LS, Kale VP. Cryopreservation of human hematopoietic cells with membrane stabilizers and bioantioxidants as additives in the conventional freezing medium. J Hematother Stem Cell Res. 2001;10:709–718. [PubMed] [Google Scholar]
27. Clappison G, Salinas C, Malacher P, Michallet M, Philip I, Philip T. Cryopreservation with hydroxyethylstarhc (HES) + dimethylsulfoxide (DMSO) gives better results than DMSO alone. Bull Cancer. 2004;1:97–102. [PubMed] [Google Scholar]
28. Kudo Y, Minegishi M, Itoh T, Miura J, Saito N, Takahashi H, et al. Evaluation of hematological reconstitution potential of autologous peripheral blood progenitor cells cryopreserved by a simple controlled-rate freezing method. Tohoku J Exp Med. 2005;205:37–43. [PubMed] [Google Scholar]
29. Carvalho KA, Cury CC, Oliveira L, Cattaned RI, Malvezzi M, Francisco JC, et al. Evaluation of bone marrow mesenchymal stem cell standard cryopreservation procedure efficiency. Transplant Proc. 2008;40:839–841. [PubMed] [Google Scholar]
30. Heng BC. Effect of Rho-associated kinase (ROCK) inhibitor Y-27632 on the post-thaw viability of cryopreserved human bone marrow-derived mesenchymal stem cells. Tissue Cell. 2009 [PubMed] [Google Scholar]
31. Kotobuki N, Hirose M, Machida H, Katou Y, Muraki K, Takakura Y, Ohgushi H. Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells. Tissue Eng. 2005;11:663–673. [PubMed] [Google Scholar]
32. Pal R, Hanwate M, Totey SM. Effect of holding time, temperature and different parenteral solutions on viability and functionality of adult bone marrow-derived mesenchymal stem cells before transplantation. J Tissue Eng Regen Med. 2008;2:436–444. [PubMed] [Google Scholar]
33. Moon JH, Lee JR, Jee BC, Suh CS, Kim SH, Lim HJ, Kim HK. Successful vitrification of human amnion-derived mesenchymal stem cells. Hum Reprod. 2008;23:1760–1770. [PubMed] [Google Scholar]
34. Nyberg SL, Hardin JA, Matos LE, Rivera DJ, Misra SP, Gores GJ. Cytoprotective influence of ZVAD-fmk and glycine on gel-entrapped rat hepatocytes in a bioartificial liver. Surgery. 2000;127:447–455. [PubMed] [Google Scholar]
35. Peter AT, Linde-Forsberg C. Efficacy of the anticaspase agent zVAD-fmk on post-thaw viability of canine spermatozoa. Theriogenology. 2003;59:1525–1532. [PubMed] [Google Scholar]
36. Sasnoor LM, Kale VP, Limaye LS. Prevention of apoptosis as a possible mechanism behind improved cryoprotection of hematopoietic cells by catalase and trehalose. Transplantation. 2005;80:1251–1260. [PubMed] [Google Scholar]
37. Yagi T, Hardin JA, Valenzuela YM, Miyoshi H, Gores GJ, Nyberg SL. Caspase inhibition reduces apoptotic death of cryopreserved porcine hepatocytes. Hepatology. 2001;33:1432–1440. [PubMed] [Google Scholar]
38. Pegg DE. Viability assays for preserved cells, tissues and organs. Cryobiology. 1989;26:212–231. [PubMed] [Google Scholar]
39. Syme R, Bewick M, Stewart D, Porter K, Chadderton T, Gluck S. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects and toxicity. Biol Blood Marrow Transplant. 2004;10:135–141. [PubMed] [Google Scholar]
40. Kuleshova LL, MacFarlane DR, Trounson AO, Shaw JM. Sugars exert a major influence on the vitrification properties of ethylene glycol-based solutions and have low toxicity to embryos and oocytes. Cryobiology. 1999;38:119–130. [PubMed] [Google Scholar]
41. Li Y, Tan JC, Li LS. Comparison of three methods for cryopreservation of human embryonic stem cells. Fertil Steril. 2008 [PubMed] [Google Scholar]
42. Reubinoff BE, Pera MF, Vajta G, Trounson AO. Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum Reprod. 2001;16:2187–2194. [PubMed] [Google Scholar]
43. Richards M, Fong CY, Tan S, Chan WK, Bongso A. An efficient and safe xeno-free cryopreservation method for the storage of human embryonic stem cells. Stem Cells. 2004;22:779–789. [PubMed] [Google Scholar]
44. Ha SY, Jee BC, Suh CS, Kim HS, Oh SK, Kim SH, Moon SY. Cryopreservation of human embryonic stem cells without the use of a programmable freezer. Hum Reprod. 2005;20:1779–1785. [PubMed] [Google Scholar]
45. Katkov II, Kim MS, Bajpai R, Altman YS, Mercola M, Loring JF, et al. Cryopreservation by slow cooling with DMSO diminished production of Oct-4 pluripotency marker in human embryonic stem cells. Cryobiology. 2006;53:194–205. [PubMed] [Google Scholar]
46. Nie Y, Bergendahl V, Hei DJ, Jones JM, Palecek SP. Scalable culture and cryopreservation of human embryonic stem cells on microcarriers. Biotechnol Prog. 2009;25:20–31. [PMC free article] [PubMed] [Google Scholar]
47. Kim SJ, Park JH, Lee JE, Kim JM, Lee JB, Moon SY, et al. Effects of type IV collagen and laminin on the cryopreservation of human embryonic stem cells. Stem Cells. 2004;22:950–961. [PubMed] [Google Scholar]
48. Zhang XB, Li K, Yau KH, Tsang KS, Fok TF, Li CK, et al. Trehalose ameliorates the cryopreservation of cord blood in a preclinical system and increases the recovery of CFUs, long-term culture-initiating cells, and nonobese diabetic-SCID repopulating cells. Transfusion. 2003;43:265–272. [PubMed] [Google Scholar]
49. Watanabe K, Ueno M, Kamiya D, Nishiyama A, Matsumura M, Wataya T, et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol. 2007;25:681–686. [PubMed] [Google Scholar]
50. Wusteman MC, Hunt CJ. The scientific basis for tissue banking. In: Fuller BJ, Lane N, Benson E, editors. Life in the Frozen State. Boca Raton, FL: CRC Press; 2004. [Google Scholar]
51. Martin-Ibanez R, Unger C, Stromberg A, Baker D, Canals JM, Hovatta O. Novel cryopreservation method for dissociated human embryonic stem cells in the presence of a ROCK inhibitor. Hum Reprod. 2008;23:2744–2754. [PubMed] [Google Scholar]
52. Ji L, de Pablo JJ, Palecek SP. Cryopreservation of adherent human embryonic stem cells. Biotechnol Bioeng. 2004;88:299–312. [PubMed] [Google Scholar]
